TNXP: Tonix Pharmaceuticals Inc. Kompaniya qiymatining sof foydaga nisbati

Tonix Pharma (TNXP) korporativ emblemasi va logotipi

Tonix Pharmaceuticals (TNXP) kompaniyasining tarixiy narxlar dinamikasi, bunda ko'rsatkich -0.30 darajasida turibdi, qat'iy tartibga soluvchi nazorat va patent urushlari bilan boshqariladi. Daromadli mahsulotlarning yetishmasligi firmani yangi qimmatli qog'ozlarni chiqarish orqali kapitalni jalb qilishga majbur qilmoqda. Tadqiqotlar barqarorligi Massachusetts va Merilanddagi laboratoriyalarda uskunalarning dublikatsiyalanishi orqali ta'minlanadi, bu esa kompaniyaning diversifikatsiyalashgan biofarmatsevtika operatsiyalarini qo'llab-quvvatlaydi.

TNXP Tonix Pharmaceuticals Holding: Narx-foyda koeffitsiyenti 04.07.2022 - 15.11.2026 oraligʻida

Tonix Pharma (TNXP) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Tonix Pharmaceuticals Inc. - TNXP
Tonix Pharmaceuticals Holding Corp. yetakchi tovari

Investorlar risklarni minimallashtirish uchun Tonix Pharmaceuticals (TNXP) bozor qiymatini uning haqiqiy rentabelligiga nisbatan tanqidiy baholashlari kerak. Kompaniyaning operatsion modeli tashqi hamkorlarning ishtirokisiz, hukumat grantlari va ichki ishlanmalarga tayanadi. Kompaniyaning fundamental P/E ko'rsatkichini tahlil qilish orqali siz bozor kapitalizatsiyasining sof foydaga nisbatini o'lchaysiz, bu esa kelajakdagi kutishlarga asoslangan haddan tashqari to'lovlarni aniqlash imkonini beradi. Ushbu ko'rsatkich investitsiya jozibadorligi darajasini va biznesning moliyaviy barqarorligini belgilaydi.

Raqobatdosh kompaniyalar

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|Narxning foydaga nisbati China SXT Pharmaceuticals, Inc.|EPRX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHST|EXOZ - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ORMP (oramed.com)|P/E multiplikatori enterabio.com ENTX|HYFT - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati ABVC BioPharma, Inc ABVC|CPIX: P/E multiplikatori|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)